ImmunityBio, Inc. (IBRX)

Healthcare · Biotechnology · NASDAQ

ImmunityBio, Inc. (IBRX) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $8.10B and a free-cash-flow yield of -4.4%. Over the most recent reported fiscal year, revenue grew 668.3%.

Market cap	$8.10B
Trailing P/E	—
FCF yield	-4.4%
Revenue growth (YoY)	+668.3%
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live IBRX data on Nama Insights →

Recent Congressional trades

ImmunityBio, Inc. trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Daniel Goldman	House	Sell	$1,001 - $15,000	Apr 3, 2023